These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29261739)

  • 1. Relation between cost of drug treatment and body mass index in people with type 2 diabetes in Latin America.
    Elgart JF; Prestes M; Gonzalez L; Rucci E; Gagliardino JJ;
    PLoS One; 2017; 12(12):e0189755. PubMed ID: 29261739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug treatment of type 2 diabetes: Its cost is significantly associated with HbA1c levels.
    Elgart JF; Silvestrini C; Prestes M; Gonzalez L; Rucci E; Gagliardino JJ
    Int J Clin Pract; 2019 Apr; 73(4):e13336. PubMed ID: 30811770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index and insulin use as identifiers of high-cost patients with type 2 diabetes: A retrospective analysis of electronic health records linked to insurance claims data.
    Johnston SS; Ammann EM; Kashyap SR; Stokes A; Hsiao CC; Daskiran M; Scamuffa R
    Diabetes Obes Metab; 2019 Jun; 21(6):1419-1428. PubMed ID: 30768824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin therapy, glycemic control, and cardiovascular risk factors in young Latin Americans with type 2 diabetes mellitus.
    Avilés-Santa L; Salinas K; Adams-Huet B; Raskin P
    J Investig Med; 2006 Jan; 54(1):20-31. PubMed ID: 16409887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching from sitagliptin to liraglutide to manage patients with type 2 diabetes in the UK: A long-term cost-effectiveness analysis.
    Barnett AH; Arnoldini S; Hunt B; Subramanian G; Hoxer CS
    Diabetes Obes Metab; 2018 Aug; 20(8):1921-1927. PubMed ID: 29652101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic and Clinical Profiles of Type 2 Diabetes Mellitus Patients Initiating Canagliflozin Versus DPP-4 Inhibitors in a Large U.S. Managed Care Population.
    Grabner M; Peng X; Geremakis C; Bae J
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1204-12. PubMed ID: 26679969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the quality of care for diabetic patients in Latin America].
    Gagliardino JJ; de la Hera M; Siri F;
    Rev Panam Salud Publica; 2001 Nov; 10(5):309-17. PubMed ID: 11774802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linagliptin plus metformin in patients with newly diagnosed type 2 diabetes and marked hyperglycemia.
    Ross SA; Caballero AE; Del Prato S; Gallwitz B; Lewis-D'Agostino D; Bailes Z; Thiemann S; Patel S; Woerle HJ; von Eynatten M
    Postgrad Med; 2016 Nov; 128(8):747-754. PubMed ID: 27684308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage.
    Vázquez LA; Rodríguez Á; Salvador J; Ascaso JF; Petto H; Reviriego J
    BMC Cardiovasc Disord; 2014 Nov; 14():153. PubMed ID: 25361574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of hyperglycemia and obesity on hospitalization costs and clinical outcome in general surgery patients.
    Buehler L; Fayfman M; Alexopoulos AS; Zhao L; Farrokhi F; Weaver J; Smiley-Byrd D; Pasquel FJ; Vellanki P; Umpierrez GE
    J Diabetes Complications; 2015; 29(8):1177-82. PubMed ID: 26355027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of baseline body mass index on glycemic control and weight change with exenatide monotherapy in Chinese drug-naïve type 2 diabetic patients.
    Deng H; Lin S; Yang X; Lv J; Luo S; Zeng L; Weng J; Xu W;
    J Diabetes; 2019 Jul; 11(7):509-518. PubMed ID: 30520243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight gain in insulin-treated patients by body mass index category at treatment initiation: new evidence from real-world data in patients with type 2 diabetes.
    Paul SK; Shaw JE; Montvida O; Klein K
    Diabetes Obes Metab; 2016 Dec; 18(12):1244-1252. PubMed ID: 27502528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription Patterns and the Cost of Antihyperglycemic Drugs in Patients With Type 2 Diabetes Mellitus in Germany.
    Jacob L; von Vultee C; Kostev K
    J Diabetes Sci Technol; 2017 Jan; 11(1):123-127. PubMed ID: 27402240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses.
    McGlone ER; Carey I; Veličković V; Chana P; Mahawar K; Batterham RL; Hopkins J; Walton P; Kinsman R; Byrne J; Somers S; Kerrigan D; Menon V; Borg C; Ahmed A; Sgromo B; Cheruvu C; Bano G; Leonard C; Thom H; le Roux CW; Reddy M; Welbourn R; Small P; Khan OA
    PLoS Med; 2020 Dec; 17(12):e1003228. PubMed ID: 33285553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of dapagliflozin versus sulfonylurea as an add-on to metformin in the treatment of Type 2 diabetes mellitus.
    Charokopou M; McEwan P; Lister S; Callan L; Bergenheim K; Tolley K; Postema R; Townsend R; Roudaut M
    Diabet Med; 2015 Jul; 32(7):890-8. PubMed ID: 25817050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost comparison of long-acting insulin analogs vs NPH insulin-based treatment in patients with type 2 diabetes using routinely collected primary care data from the UK.
    Idris I; Gordon J; Tilling C; Vora J
    J Med Econ; 2015 Apr; 18(4):273-82. PubMed ID: 25422990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of clinical and cost outcomes associated with earlier initiation of insulin in patients with type 2 diabetes mellitus.
    Smolen HJ; Murphy DR; Gahn JC; Yu X; Curtis BH
    J Manag Care Spec Pharm; 2014 Sep; 20(9):968-84. PubMed ID: 25166296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS.
    Pagidipati NJ; Zheng Y; Green JB; McGuire DK; Mentz RJ; Shah S; Aschner P; Delibasi T; Rodbard HW; Westerhout CM; Holman RR; Peterson ED;
    Am Heart J; 2020 Jan; 219():47-57. PubMed ID: 31707324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multiethnic Study of Pre-Diabetes and Diabetes in LMIC.
    Shen J; Kondal D; Rubinstein A; Irazola V; Gutierrez L; Miranda JJ; Bernabé-Ortiz A; Lazo-Porras M; Levitt N; Steyn K; Bobrow K; Ali MK; Prabhakaran D; Tandon N
    Glob Heart; 2016 Mar; 11(1):61-70. PubMed ID: 27102023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.